Hypermarcas (OTCMKTS:HYPMY) Stock Price Passes Above Fifty Day Moving Average – Time to Sell?

Hypermarcas (OTCMKTS:HYPMY) passed above its fifty day moving average during trading on Friday . The stock has a fifty day moving average of $4.51 and traded as high as $4.51. Hypermarcas shares last traded at $4.41, with a volume of 33,566 shares.

Wall Street Analysts Forecast Growth

Separately, Zacks Research upgraded Hypermarcas to a “hold” rating in a research note on Wednesday, April 29th. One research analyst has rated the stock with a Strong Buy rating and one has given a Hold rating to the company’s stock. Based on data from MarketBeat, the company presently has an average rating of “Buy”.

Hypermarcas Stock Performance

The stock has a market capitalization of $3.10 billion, a PE ratio of 9.19 and a beta of 0.73. The company has a quick ratio of 0.84, a current ratio of 1.27 and a debt-to-equity ratio of 0.61. The firm has a 50 day moving average price of $4.51 and a 200-day moving average price of $4.52.

Hypermarcas (OTCMKTS:HYPMY) last announced its quarterly earnings data on Wednesday, April 29th. The company reported $0.10 earnings per share (EPS) for the quarter. Hypermarcas had a return on equity of 14.08% and a net margin of 19.41%.The firm had revenue of $383.13 million during the quarter. Research analysts expect that Hypermarcas will post 0.53 EPS for the current fiscal year.

About Hypermarcas

Hypermarcas SA is a Brazil-based consumer health and pharmaceutical company whose shares trade over the counter in the United States under the symbol HYPMY. Founded in the early 2000s and headquartered in Rio de Janeiro, the company operates as a holding group for a broad portfolio of branded products in the healthcare and personal care sectors.

Through its various subsidiaries, Hypermarcas develops, manufactures and markets prescription and over-the-counter medications, alongside personal care, baby care, home care and nutritional supplement products.